| 股票代码 | 300357 | 当期评分 | ||||
| 股票名称 | 我武生物 | |||||
| 报告日期 | 2018-12-31 | 2019-12-31 | 2020-09-30 | 2020-09-30 | 2020-09-30 | 2020-09-30 |
| 每股经营现金流(¥) | 0.7098 | 0.4449 | 0.3654 | 0.3654 | 0.3654 | ✘ |
| 销售净利润率(%) | 46.3039 | 45.7682 | 45.4888 | 45.4888 | 45.4888 | ✔ |
| 销售毛利率(%) | 93.7613 | 95.9141 | 94.9682 | 94.9682 | 94.9682 | ✔ |
| 净资产收益率(%) | 24.02 | 23.47 | 16.3 | 16.3 | 16.3 | ✘ |
| 营业增长率(%) | 29.869 | 27.6804 | -1.7881 | -1.7881 | -1.7881 | ✘ |
| 净利润增长率(%) | 24.5886 | 26.2032 | -8.0071 | -8.0071 | -8.0071 | ✘ |
| 每股收益(%) | 0.8006 | 0.5697 | 0.2045 | 0.079 | 0.4376 | ✔ |
| 现金流量比率(%) | 358.3076 | 388.0178 | 255.8921 | 155.6998 | 295.3205 | ✔ |
| 三项费用比重(%) | 38.1971 | 35.9431 | 37.4875 | 43.0875 | 33.4661 | ✔ |
| 每股净资产(¥) | 3.333 | 2.4275 | 2.452 | 2.5065 | 2.6851 | ✔ |
| 流动比率(%) | 13.566 | 17.4914 | 21.6364 | 24.3622 | 17.7027 | ✔ |
| 速动比率(%) | 13.1586 | 16.8781 | 20.8101 | 23.4591 | 17.1333 | ✔ |
| 现金比率(%) | 798.4254 | 1250.6682 | 1639.3917 | 1844.9693 | 1844.9693 | ✔ |
| 总资产利润率(%) | 24.3273 | 23.5405 | 7.2937 | 2.7936 | 14.9398 | ✔ |
| 主营利润比重% | 171.991 | 177.3795 | 197.0989 | 218.8475 | 175.3216 | ✔ |
| 应收账款(万元) | 10,876.83 | 13,350.85 | 13,884.88 | 12,675.56 | 19,334.99 | ✘ |
| 应收票据(万元) | 5,322.99 | 6,472.68 | 2,678.07 | 2,760.65 | 4,654.98 | ✘ |
| 预付款项(万元) | 877.66 | 473.90 | 494.82 | 477.43 | 759.29 | ✔ |
| 存货(万元) | 2,347.31 | 3,681.90 | 3,915.90 | 3,928.11 | 3,689.32 | ✔ |
| 在建工程(万元) | 1,802.65 | 4,267.97 | 5,762.38 | 5,275.52 | 6,918.31 | ✔ |
| 应付款项(万元) | 344.75 | 868.44 | 621.82 | 461.67 | 622.76 | ✘ |
| 长期借款(万元) | -- | -- | -- | -- | -- | ✔ |
| 未分配利润(万元) | 53,256.28 | 49,430.12 | 50,711.13 | 53,566.99 | 62,918.67 | ✔ |
| 商誉(万元) | -- | -- | -- | -- | -- | ✔ |
| 流动资产(万元) | 27,623.41 | 37,820.75 | 39,984.76 | 39,230.61 | 41,525.73 | ✘ |
| 流动负债(万元) | 5,761.88 | 6,002.96 | 4,739.55 | 4,349.38 | 6,478.63 | ✘ |
我武生物300357评分结果 | 57.58分 | 卖出/减持 | ||||